Genetic studies of EBS patients as well as experiments with transgenic cells and mice [10], [11], [12] provide compelling evidence for a causal link between mutations in K5/K14 genes and EBS, although the exact biophysical mechanism of basal keratinocyte fragility in EBS patients remains unknown. The gene discussed is KRT5; the disease is epidermolysis bullosa simplex.